Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide does not modulate kainate receptor binding in human brain

R D Lees1, P Slater, S W D'Souza

  • 1School of Biological Sciences, University of Manchester, UK. rlees@man.ac.uk

Neuroscience Letters
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical hypnosis and the anaesthetist: a practical approach.

BJA education·2024
Same author

Altermagnetic lifting of Kramers spin degeneracy.

Nature·2024
Same author

What do young adults know about palliative care? A cross-sectional survey.

Public health·2021
Same author

An international study of public contact with people who have an intellectual disability.

Journal of intellectual disability research : JIDR·2021
Same author

Néel Vector Induced Manipulation of Valence States in the Collinear Antiferromagnet Mn<sub>2</sub>Au.

ACS nano·2020
Same author

Robust Bain distortion in the premartensite phase of a platinum-substituted Ni<sub>2</sub>MnGa magnetic shape memory alloy.

Nature communications·2017

Nitric oxide (NO) does not affect kainate receptor binding in human brain tissue. This suggests that endogenous NO does not modulate kainate receptors in vivo, contrary to other glutamate receptors.

Area of Science:

  • Neuroscience
  • Neurochemistry
  • Pharmacology

Background:

  • Nitric oxide (NO) is a signaling molecule implicated in various physiological processes, including neurotransmission.
  • Ionotropic glutamate receptors, such as kainate receptors, play crucial roles in synaptic plasticity and neuronal excitability.
  • The interaction between NO and glutamate receptors is complex and receptor-specific.

Purpose of the Study:

  • To investigate whether nitric oxide (NO) donors can alter ligand binding to kainate receptors in human brain tissue.
  • To determine if endogenous NO modulates kainate receptor function in vivo.

Main Methods:

  • Human adult autopsy brain tissue (frontal cortex, Brodmann areas 8 and 9) was used.
  • Ligand binding assays with [3H]kainic acid were performed in the presence of three NO donor compounds: SNAP, Cys-NO, and SIN-1.

Related Experiment Videos

  • Autoradiography was employed to visualize binding patterns.
  • Nitrite accumulation assays confirmed NO release under experimental conditions.

    • Main Results:

    • None of the tested NO donor compounds (SNAP, Cys-NO, SIN-1) altered the specific binding of [3H]kainic acid to kainate receptors.
    • Adequate NO release from the donors was confirmed during ligand binding assays.
    • Kainate receptor binding remained unaffected by NO, unlike other ionotropic glutamate receptors.

    Conclusions:

    • Nitric oxide (NO) does not directly modulate ligand binding to kainate receptors in the human brain.
    • Endogenous NO produced by NO synthase (NOS) is unlikely to regulate kainate receptor activity in vivo.
    • Alternative mechanisms, possibly involving altered modulation of NMDA receptors, may explain the effects of NOS inhibitors on kainic acid-induced seizures.